This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Xplore Announces $2.2 Million In Purchase Orders

Xplore Technologies Corp. (OTCQB: XLRT) (“Xplore” or the “Company”), a manufacturer of award-winning rugged tablet PCs, announced today that it received $2.2 million in purchase orders for the week ended October 12, 2012. Approximately $1.1 million of these purchase orders were received from a leading medical device company focused on advanced heart failure solutions, with the balance coming from a number of existing customers, such as Daimler, and partners, such as VT Miltope for the US Air Force.

“Sales of tablet computers continue to gain momentum and market share,” stated Philip Sassower, Xplore’s Chairman and Chief Executive Officer. “We believe Xplore’s improved operating results are directly linked to the tablet computer becoming the device of choice for field applications and last week’s purchase orders are a further indication of this positive trend for our sector. With our market-leading family of rugged devices, we believe Xplore should be a significant beneficiary of the tablet form factor’s increasing popularity.”

“We believe last week’s $2.2 million in total purchase orders demonstrate our Fortune 500 customers’ ongoing commitment to our products and our ability to attract significant orders from new large customers,” stated Mark Holleran, Xplore’s President and Chief Operating Officer. “The value of Xplore’s products has become more recognized with blue chip companies such as AT&T that rely on the quality of our products to guarantee availability of their field solutions and a lower total cost of ownership compared to non-rugged and semi-rugged alternatives.”

“After receiving approximately $20.3 million in purchase orders in fiscal 2012 from AT&T and from a prominent oil and natural gas exploration company, last week’s $1.1 million purchase order from a leading medical device company represents yet another significant win in a new vertical market for us. Our new customer plans to employ the iX104 as the control unit for its advanced treatment solutions to ensure that a patient’s health cannot be negatively affected by a computing hardware failure.”

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,684.94 +6.71 0.04%
S&P 500 2,058.81 +2.66 0.13%
NASDAQ 4,875.09 +11.7280 0.24%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs